Epsilon Net: Dynamic entry into the pharmacy software market with the acquisition of 100% of CSA

EPSILON NET announced an agreement to acquire a 100% stake in the company under the name “SOTIRIS MATSOUKAS SA INFORMATICS” and the distinctive title “CSA”, which is active in the development of specialized IT solutions and automation systems for pharmacies and companies operating in its field. marketing & distribution of the drug in Greece (www.csagreece.com).

CSA has been active since 1985 in software development for small and large commercial enterprises, constantly investing in cutting-edge technologies and human resources so that its applications offer a high level of usability and interoperability. The company has complete applications and solutions in the field of medicine and more specifically:

➢ The FARMAKON application for pharmacies – retail outlets. The application has been developed and fully covers the needs of the Greek pharmacy in connection with IDIKA, EOPPY and other insurance funds

➢ The specialized information system FARMAKON ERP for drugstores and wholesale companies active in the fields of medicines, parapharmaceuticals and cosmetics.

Σης Application of connection with the German technology robotic systems ROWA Vmax for automation in product management and execution of orders.

The systematic and long-term effort of the management of the company and its executives, have led CSA to a leading position with a share of over 50% in the specific vertical market of the drug and to serve with software solutions of more than 5,200 pharmacies in the total of approximately 10,400 operating throughout Greece (according to ELSTAT data for 2020). It is worth noting that the Greek pharmacy has now emerged as a key point of provision of primary health services (influenza vaccination services, rapid test) and the field of medicine and health in general, is one of the most privileged sectors in terms of innovation development. , technological automation and Business Intelligence (BI) systems resulting in the exceptional dynamics of the pharmacy sector and the pharmaceutical & para-pharmaceutical sector in general, to constantly create new needs for additional functionality in the use of software using the Web and Cloud systems.

This trend is particularly strong recently due to COVID-19 and will be the basis for the further future development of the company with the support of the Epsilon Net Group. At the same time, based on its complete contribution to the Digital Transformation of the private sector, both for pharmacies and drug marketing companies, as well as for all other sectors in which it operates, the Group has analyzed all the new financing opportunities that will arise in the near future. from the financial instruments of the “Recovery and Durability Fund” & the “NSRF 2021-2027. will amount to 2.73 million Euros.

The company’s turnover for the year 2021, amounted to 2.75 million euros with an estimated EBITDA of 455 thousand euros and estimated pre-tax profits for 2021 of 380 thousand euros. It is noted that on 31/12/2021 the company had cash and cash equivalents of 295 thousand euros and loans of 386 thousand euros, while it should be emphasized that the company also owns an autonomous office complex of offices and warehouses on a main road in the Municipality of Agia Made in Attica with an estimated commercial value of approximately 1 million euros. This acquisition, on the one hand, implements the strategic planning of EPSILON NET for entering special vertical markets, providing innovative products and services with the aim of expanding the customer base, on the other hand, is the first step for the gradual expansion of the Group’s activities in IT systems. the Health sector.

The Group consistently and continuously follows its business planning at the level of continuous organic development, while at the same time it proceeds with acquisitions and technological collaborations in order to increase its market shares and the total of its financial figures.

Mr. Ioannis Michos, Founder of the Group, Chairman of the Board & CEO of EPSILON NET, stated the following:

“2021 was a milestone year for our Group. As we have already estimated, the success of 2021 will be the beginning of a new creative cycle, with strong growth rates in the sectors in which the company operates with an emphasis on Web and Cloud technologies. With the accession of CSA, we begin our activity in the special field of information systems for Health. Together with the CSA executives, we have designed and will implement a comprehensive plan to upgrade the company’s systems and create new tools for the Hellenic Pharmacy and the wider Pharmaceutical sector. The large family of companies of the Epsilon Net Group, continues with vision, anthropocentric approach and dedication to serving the needs of our customers. Our main goal remains to produce daily value for our people, our partners and our shareholders. “Mr. Christos Delimargas, Chairman of the Board & CEO of CSA, stated the following:” After 36 years of creative progress in the field of IT and having created a series of renowned applications for pharmacies and companies active in the marketing of the drug, our company it’s time to start a new page in its successful course and join the large family of the Epsilon Net Group. With the management and technology team of Epsilon Net we have already planned the implementation of an innovative plan to upgrade our applications and create new tools & services for the Greek Pharmacist and companies operating in the wider health sector, with emphasis on Cloud technologies and E -commerce. I would like to especially thank the thousands of customers of our company for our long-term cooperation & their trust and especially our executives & staff for their daily effort and contribution over the past years. With the help of the Epsilon Net Group, we all continue together, next to our customers guided by our many years of experience and technological innovation“.